Product References
The c-Myc Oncogene Maintains Corneal Epithelial Architecture at Homeostasis, Modulates p63 Expression, and Enhances Proliferation During Tissue Repair.
Investigative ophthalmology & visual science
Portal C,Wang Z,Scott DK,Wolosin JM,Iomini C
14-5785-81 was used in Western Blot to show that Myc regulates the balance among CE stratification, differentiation, and surface exfoliation and promotes the transition to the hyperproliferative state during wound healing.
Tue Feb 01 00:00:00 EST 2022
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.
Cell death & disease
Islam SS,Qassem K,Islam S,Parag RR,Rahman MZ,Farhat WA,Yeger H,Aboussekhra A,Karakas B,Noman ASM
14-5785-81 was used in Western Blotting to suggest that Keap1 mutations define a distinct disease phenotype and the Keap1-Nrf2 pathway is one of the leading molecular mechanisms for clinical chemotherapeutic resistance.
Tue Aug 09 00:00:00 EDT 2022
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.
Cell death & disease
Islam SS,Qassem K,Islam S,Parag RR,Rahman MZ,Farhat WA,Yeger H,Aboussekhra A,Karakas B,Noman ASM
14-5785-81 was used in Western Blotting to suggest that Keap1 mutations define a distinct disease phenotype and the Keap1-Nrf2 pathway is one of the leading molecular mechanisms for clinical chemotherapeutic resistance.
Tue Aug 09 00:00:00 EDT 2022
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.
Cell death & disease
Islam SS,Qassem K,Islam S,Parag RR,Rahman MZ,Farhat WA,Yeger H,Aboussekhra A,Karakas B,Noman ASM
14-5785-81 was used in Western Blotting to suggest that Keap1 mutations define a distinct disease phenotype and the Keap1-Nrf2 pathway is one of the leading molecular mechanisms for clinical chemotherapeutic resistance.
Tue Aug 09 00:00:00 EDT 2022
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
Haematologica
Larose H,Prokoph N,Matthews JD,Schlederer M,Högler S,Alsulami AF,Ducray SP,Nuglozeh E,Fazaludeen FMS,Elmouna A,Ceccon M,Mologni L,Gambacorti-Passerini C,Hoefler G,Lobello C,Pospisilova S,Janikova A,Woessmann W,Damm-Welk C,Zimmermann M,Federova A,Malone A,Smith O,Wasik M,Inghirami G,Lamant L,Blundell TL,Klapper W,Merkel O,Burke AGA,Mian S,Ashankyty I,Kenner L,Turner SD
14-5785-81 was used in Western Blot to identify a variant in the extracellular domain of NOTCH1 that provides a growth advantage to cells and confirm the suitability of the Notch pathway as a second-line druggable target in Anaplastic Lymphoma Kinase and Anaplastic Large Cell Lymphoma, using Whole-Exome Sequencing.
Tue Jun 01 00:00:00 EDT 2021
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
Haematologica
Larose H,Prokoph N,Matthews JD,Schlederer M,Högler S,Alsulami AF,Ducray SP,Nuglozeh E,Fazaludeen FMS,Elmouna A,Ceccon M,Mologni L,Gambacorti-Passerini C,Hoefler G,Lobello C,Pospisilova S,Janikova A,Woessmann W,Damm-Welk C,Zimmermann M,Federova A,Malone A,Smith O,Wasik M,Inghirami G,Lamant L,Blundell TL,Klapper W,Merkel O,Burke AGA,Mian S,Ashankyty I,Kenner L,Turner SD
14-5785-81 was used in Western Blot to identify a variant in the extracellular domain of NOTCH1 that provides a growth advantage to cells and confirm the suitability of the Notch pathway as a second-line druggable target in Anaplastic Lymphoma Kinase and Anaplastic Large Cell Lymphoma, using Whole-Exome Sequencing.
Tue Jun 01 00:00:00 EDT 2021
FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.
International journal of molecular medicine
Skarmoutsou E,Bevelacqua V,D' Amico F,Russo A,Spandidos DA,Scalisi A,Malaponte G,Guarneri C
14-5785 was used in Western Blotting to demonstrate that NOTCH1 is a central mediator of TGF-β-mediated FOXP3 expression and NOTCH1 inhibition reduces melanoma cell proliferation and viability.
Sun Jul 01 00:00:00 EDT 2018
FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.
International journal of molecular medicine
Skarmoutsou E,Bevelacqua V,D' Amico F,Russo A,Spandidos DA,Scalisi A,Malaponte G,Guarneri C
14-5785 was used in Western Blotting to demonstrate that NOTCH1 is a central mediator of TGF-β-mediated FOXP3 expression and NOTCH1 inhibition reduces melanoma cell proliferation and viability.
Sun Jul 01 00:00:00 EDT 2018
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.
The Journal of experimental medicine
Roderick JE,Gonzalez-Perez G,Kuksin CA,Dongre A,Roberts ER,Srinivasan J,Andrzejewski C,Fauq AH,Golde TE,Miele L,Minter LM
14-5785 was used in Flow cytometry/Cell sorting to identify NOTCH signaling as a primary driver of Th1-mediated pathogenesis in AA and may represent a novel target for therapeutic intervention.
Mon Jul 01 00:00:00 EDT 2013
Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.
Molecular therapy : the journal of the American Society of Gene Therapy
Tezgel AÖ,Gonzalez-Perez G,Telfer JC,Osborne BA,Minter LM,Tew GN
14-5785 was used in Western Blotting to develop a novel system for intracellular delivery of siRNA molecules.
Tue Jan 01 00:00:00 EST 2013
Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.
The Journal of experimental medicine
Billiard F,Lobry C,Darrasse-Jèze G,Waite J,Liu X,Mouquet H,DaNave A,Tait M,Idoyaga J,Leboeuf M,Kyratsous CA,Burton J,Kalter J,Klinakis A,Zhang W,Thurston G,Merad M,Steinman RM,Murphy AJ,Yancopoulos GD,Aifantis I,Skokos D
14-5785 was used in Flow cytometry/Cell sorting to investigate how Dll4-Notch signaling affects pro-T cell fate and thymic DC development, showing that it is a novel Flt3-independent pathway for DC development and autoimmunity.
Mon May 07 00:00:00 EDT 2012
Notch signaling regulates mouse and human Th17 differentiation.
Journal of immunology (Baltimore, Md. : 1950)
Keerthivasan S,Suleiman R,Lawlor R,Roderick J,Bates T,Minter L,Anguita J,Juncadella I,Nickoloff BJ,Le Poole IC,Miele L,Osborne BA
14-5785 was used as a Control in experiments to highlight the importance of Notch signaling in Th17 differentiation and indicate that selective targeted therapy against Notch may be an important tool to treat autoimmune disorders, including multiple sclerosis.
Fri Jul 15 00:00:00 EDT 2011
Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.
The American journal of pathology
Yan H,Blackburn AC,McLary SC,Tao L,Roberts AL,Xavier EA,Dickinson ES,Seo JH,Arenas RB,Otis CN,Cao QJ,Lawlor RG,Osborne BA,Kittrell FS,Medina D,Jerry DJ
14-5785 was used in Western Blotting to produce a panel of 28 transplantable tumors as resource for preclinical testing of therapeutic agents targeting cancer stem cells or oncogenic changes occurring during the progression from locally invasive to metastatic breast cancer.
Mon Mar 01 00:00:00 EST 2010